Evaluation and management of treatment-related diarrhea in patients with advanced cancer: A review

被引:41
作者
Cherny, Nathan I. [1 ]
机构
[1] Shaare Zedek Med Ctr, Canc Pain & Palliat Med Serv, Dept Oncol, IL-91031 Jerusalem, Israel
关键词
diarrhea; adverse effects; diagnosis; assessment; management; palliative care; advanced cancer;
D O I
10.1016/j.jpainsymman.2007.10.007
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Diarrhea is a common and significant problem among patients with advanced cancer. Treatment-induced diarrhea can be severe and be associated with life-threatening dehydration and electrolyte abnormalities. The causes of diarrhea among patients with advanced cancer are diverse and some causes of diarrhea require specific therapies. Thus, careful evaluation of the underlying cause is necessary. Palliative care clinicians, particularly those dealing with patients receiving ongoing disease-modifying therapies, must be familiar with the common causes of diarrhea among cancer patients and the strategies to evaluate and manage these common and distressing symptoms. This article addresses four major issues: 1) a review of the causes of treatment-related diarrhea, focusing on diarrhea caused by chemotherapy, targeted therapies, and radiotherapy; 2) differential diagnosis and an approach to evaluation; 3) general management considerations; and 4) cause-specific issues in management.
引用
收藏
页码:413 / 423
页数:11
相关论文
共 84 条
[1]   IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA [J].
ABIGERGES, D ;
ARMAND, JP ;
CHABOT, GG ;
DACOSTA, L ;
FADEL, E ;
COTE, C ;
HERAIT, P ;
GANDIA, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :446-449
[2]  
Alderman Jeffrey, 2005, J Palliat Med, V8, P449, DOI 10.1089/jpm.2005.8.449
[3]   New approaches to prevent intestinal toxicity of irinotecan-based regimens [J].
Alimonti, A ;
Gelibter, A ;
Pavese, I ;
Satta, F ;
Cognetti, F ;
Ferretti, G ;
Rasio, D ;
Vecchione, A ;
Di Palma, M .
CANCER TREATMENT REVIEWS, 2004, 30 (06) :555-562
[4]  
American Gastroenterological Association Medical Position Statement, 1995, GASTROENTEROLOGY, V108, P1280, DOI DOI 10.1016/0016-5085(95)90230-9
[5]  
Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227
[6]  
Avigan D, 1998, CANCER, V83, P409, DOI 10.1002/(SICI)1097-0142(19980801)83:3<409::AID-CNCR7>3.0.CO
[7]  
2-J
[8]  
Babb RR, 1996, AM J GASTROENTEROL, V91, P1309
[9]  
Bass D J, 1996, J Gerontol Nurs, V22, P37
[10]   CLINICAL AND NUTRITIONAL IMPLICATIONS OF RADIATION ENTERITIS [J].
BEER, WH ;
FAN, A ;
HALSTED, CH .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1985, 41 (01) :85-91